Light Mode
$10.61 ↑ +0.00 (+0.00%) Trading Up from the previous close of $10.61, $0.02 below the day’s high of $10.63
+4.37 (+70.03%) / 6M
Momentum, market sentiment, and recent alerts
CERT reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -15.2%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Certara, Inc. engages in the provision of software and technology-enabled services for drug developers. It offers cell and gene therapy, clinical pharmacology, complex biologics, decision analytics and modeling, drug development and regulatory strategy, and model-based analysis services. The company was founded on June 27, 2017 and is headquartered in Radnor, PA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.